Benjamin Hickey - President, RayzeBio Org. at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
President, RayzeBio Org.
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Benjamin Hickey since 4/21/2024

Holdings reported by Benjamin Hickey for Bristol Myers Squibb Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Market Share Units 13.4K $709K $52.99 Mar 10, 2025 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 8.79K $555K $63.11 Mar 10, 2025 Direct
Restricted Stock Units 6.57K $348K $52.99 Mar 1, 2025 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 780 $42K $53.79 Mar 10, 2024 Direct
Common Stock, $0.10 par value 91 $5.74K $63.11 Mar 10, 2025 By Spouse
Common Stock, $0.10 par value 91 $4.9K $53.79 Mar 10, 2024 By Spouse
Performance Shares 20.1K Mar 10, 2025 Direct Common Stock, $0.10 par value

Transactions reported by Benjamin Hickey for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.